Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 218152
Company: MSN
Company: MSN
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| PERAMPANEL | PERAMPANEL | 0.5MG/ML | SUSPENSION;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 07/11/2025 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
PERAMPANEL
SUSPENSION;ORAL; 0.5MG/ML
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| FYCOMPA | PERAMPANEL | 0.5MG/ML | SUSPENSION;ORAL | Prescription | Yes | AB | 208277 | CATALYST PHARMS |
| PERAMPANEL | PERAMPANEL | 0.5MG/ML | SUSPENSION;ORAL | Prescription | No | AB | 218152 | MSN |